View Pages
Pfizer CEO Albert Bourla: How AI Could Transform Cancer Drug Discovery
Bourla discusses AI’s potential to speed drug discovery and unlock new cancer treatments, transforming healthcare.
Editorial companion
What stands out
Pfizer CEO Albert Bourla argued that artificial intelligence can speed drug discovery and open treatment avenues that were previously unimaginable, saying these are areas "we couldnāt even dream before and we can make that a reality today." The clip matters because it is a clear, public endorsement from the head of one of the worldās largest drugmakers, framed not as academic optimism but as applied science that could shorten timelines and expand what drugs can target. Bourlaās framing shifts AI from a buzzword to an operational priority for Pfizerās research teams.